HELO Trial: Energy-Based Therapies vs. Conventional Hemorrhoidectomy for Grade III Hemorrhoids

NCT07333040 — Not applicable, Recruiting, 60 participants, Chang Gung Memorial Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Hemorrhoidectomy, Energy-Based, and Laser Outcomes in Grade III Hemorrhoids: A Prospective, Multicenter, Preference-Based Comparative Study

RegistryNCT07333040, acronym HELO
StatusRecruiting
PhaseNot applicable
Study typeInterventional; non randomized, parallel, masking: single, treatment
Enrollment60 (Estimated)
SponsorChang Gung Memorial Hospital (Other); collaborators: Taiwan Colorectal Action Research Society, New Taipei Municipal TuCheng Hospital, Jen Ai Hospital
ConditionsHemorrhoids Third Degree, Internal Hemorrhoids, Mixed Hemorrhoids
InterventionsLaser Hemorrhoidoplasty (LHP), Hemorrhoid Energy Therapy (HET), Ferguson Hemorrhoidectomy (Procedure)
Datesstart 2026-07-01, primary completion 2027-05-01 (estimated), completion 2028-03-01 (estimated), first posted 2026-01-12, last updated 2026-08-07
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
All trials for Hemorrhoids Third Degree All trials for Internal Hemorrhoids All trials of Laser Hemorrhoidoplasty (LHP) All trials of Hemorrhoid Energy Therapy (HET)

-Summary

This prospective, multicenter study compares the efficacy and functional outcomes of three surgical treatments for symptomatic Goligher Grade III internal hemorrhoids: Laser Hemorrhoidoplasty (LHP), Hemorrhoid Energy Therapy (HET), and conventional closed hemorrhoidectomy (Ferguson technique). Due to strong patient preferences in hemorrhoidal surgery, this study utilizes a pragmatic, preference-tolerant design. Eligible patients will undergo standardized counseling and select their preferred treatment arm. The study aims to evaluate whether minimally invasive energy-based therapies offer superior postoperative pain relief and faster functional recovery compared to conventional hemorrhoidectomy

Expand all sections  ·  Collapse all

+Detailed description

This prospective, multicenter trial aims to evaluate and optimize the surgical management of Goligher Grade III internal hemorrhoids. While conventional excisional hemorrhoidectomy (Ferguson technique) remains the gold standard, it is associated with significant postoperative pain and prolonged recovery. Emerging energy-based therapies, specifically Laser Hemorrhoidoplasty (LHP) and Hemorrhoid Energy Therapy (HET), offer potential advantages but their comparative efficacy remains understudied.

The study employs a pragmatic, preference-based design to reflect real-world clinical decision-making. Eligible participants will receive standardized counseling regarding three treatment options: (1) LHP, (2) HET, and (3) Conventional Hemorrhoidectomy, and will be assigned to their preferred treatment arm. To mitigate selection bias, propensity score overlap weighting (PSOW) will be utilized in the statistical analysis.

The primary objective is to compare the postoperative pain trajectory (assessed by the Area Under the Curve of NRS pain scores from Day 1 to Day 14) and the time to functional recovery among the three groups. Secondary objectives include the assessment of 12-month recurrence rates, symptom severity (HDSS), quality of life (Short Health Scale), and postoperative complications. Recurrence outcomes will be adjudicated by an independent blinded committee to minimize detection bias.

+Arms and interventions

ArmTypeInterventionsDescription
Laser Hemorrhoidoplasty (LHP)ExperimentalProcedure: Laser Hemorrhoidoplasty (LHP)1470nm or 980nm diode laser ablation
Hemorrhoid Energy Therapy (HET)ExperimentalProcedure: Hemorrhoid Energy Therapy (HET)Bipolar radiofrequency coagulation using HETâ„¢ system
Conventional HemorrhoidectomyActive comparatorProcedure: Ferguson HemorrhoidectomyStandard closed excisional hemorrhoidectomy
  • Laser Hemorrhoidoplasty (LHP) (Procedure): 1470nm or 980nm diode laser ablation
  • Hemorrhoid Energy Therapy (HET) (Procedure): Bipolar radiofrequency coagulation using HETâ„¢ system
  • Ferguson Hemorrhoidectomy (Procedure): Standard closed excisional hemorrhoidectomy

+Outcome measures

Primary outcomes

  • Time to Functional Recovery [Up to 1 month post-operation]: Days to return to work or normal daily activities.
  • Post-operative Pain Trajectory (Area Under the Curve) [Post-operative Day 1 to Day 14]: Assessed using Numeric Rating Scale (0-10). Calculated as Area Under the Curve (AUC).

Secondary outcomes

  • Recurrence Rate [12 months post-operation]: Defined as the recurrence of prolapse or bleeding requiring medical or surgical re-intervention, or deterioration in HDSS score beyond a prespecified threshold. To ensure objectivity, these events will be adjudicated by an independent committee blinded to the treatment allocation.

+Eligibility

Sex: All, ages: 18 Years to 75 Years

Inclusion Criteria:

* Diagnosed with Goligher Grade III internal hemorrhoids.
* Symptomatic with HDSS score >= 5.
* Age 18-75 years.
* Fit for general anesthesia or sedation.
* Able to provide informed consent.
* Agree to pre-operative photo documentation.

Exclusion Criteria:

* Other anorectal diseases (fistula, abscess, IBD, malignancy).
* Prior anorectal surgery within 6 months.
* Pregnancy or lactation.
* Contraindications to anesthesia.

+Locations (1)

FacilityCityCountryStatus
Chang Gung Memorial Hospital, Linkou BranchTaoyuanTaiwanRecruiting

+Publications

  • van Oostendorp JY, Dekker L, van Dieren S, Veldkamp R, Bemelman WA, Han-Geurts IJM; HollAND Study Group. Comparison of Rubber Band Ligation and Hemorrhoidectomy in Patients With Symptomatic Hemorrhoids Grade III: A Multicenter, Open-Label, Randomized Controlled Noninferiority Trial. Dis Colon Rectum. 2025 May 1;68(5):572-583. doi: 10.1097/DCR.0000000000003679. Epub 2025 Feb 14. PMID 39952268
  • Gambardella C, Brusciano L, Brillantino A, Parisi S, Lucido FS, Del Genio G, Tolone S, Allaria A, Di Saverio S, Pizza F, Sturiale A, Docimo L. Mid-term efficacy and postoperative wound management of laser hemorrhoidoplasty (LHP) vs conventional excisional hemorrhoidectomy in grade III hemorrhoidal disease: the twisting trend. Langenbecks Arch Surg. 2023 Apr 5;408(1):140. doi: 10.1007/s00423-023-02879-4. PMID 37020091
  • Hawkins AT, Davis BR, Bhama AR, Fang SH, Dawes AJ, Feingold DL, Lightner AL, Paquette IM; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Dis Colon Rectum. 2024 May 1;67(5):614-623. doi: 10.1097/DCR.0000000000003276. Epub 2024 Jan 31. No abstract available. PMID 38294832
  • Giuliani A, Romano L, Necozione S, Cofini V, Di Donato G, Schietroma M, Carlei F; EMODART3 Study Group. Excisional Hemorrhoidectomy Versus Dearterialization With Mucopexy for the Treatment of Grade III Hemorrhoidal Disease: The EMODART3 Multicenter Study. Dis Colon Rectum. 2023 Dec 1;66(12):e1254-e1263. doi: 10.1097/DCR.0000000000002885. Epub 2023 Aug 24. PMID 37616177